Tofacitinib, a JAK inhibitor, inhibits human B cell activation in vitro

Annals of the Rheumatic Diseases

Volumn 73, Issue 12, 2014, Pages 2213-2215

  Wang, Sheau Pey ^a   Iwata, Shigeru ^a   Nakayamada, Shingo ^a   Sakata, Kei ^a   Yamaoka, Kunihiro ^a   Tanaka, Yoshiya ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; IMMUNOGLOBULIN G; METHOTREXATE; PROTEIN BCL 6; TOFACITINIB; X BOX BINDING PROTEIN 1; JANUS KINASE 3; PIPERIDINE DERIVATIVE; PROTEIN KINASE INHIBITOR; PYRIMIDINE DERIVATIVE; PYRROLE DERIVATIVE;

AICDA GENE; ANTIBODY PRODUCTION; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; BCL6 GENE; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CYTOKINE PRODUCTION; DRUG EFFECT; GENE EXPRESSION; GENE REGULATORY NETWORK; HUMAN; HUMAN CELL; IN VITRO STUDY; LETTER; PRIORITY JOURNAL; XBP 1 GENE; ANTAGONISTS AND INHIBITORS; B LYMPHOCYTE; CELL DIFFERENTIATION; DRUG EFFECTS; GENE REARRANGEMENT; IMMUNOLOGY; LYMPHOCYTE ACTIVATION;

B-LYMPHOCYTES; CELL DIFFERENTIATION; HUMANS; IMMUNOGLOBULIN CLASS SWITCHING; IN VITRO TECHNIQUES; JANUS KINASE 3; LYMPHOCYTE ACTIVATION; PIPERIDINES; PROTEIN KINASE INHIBITORS; PYRIMIDINES; PYRROLES;

EID: 84922226607     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2014-205615     Document Type: Letter

References (8)

1. Ozaki K, Spolski R, Ettinger R, et al. Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J Immunol 2004;173:5361-71.
2. Zotos D, Coquet JM, Zhang Y, et al. IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism. J Exp Med 2010;207:365-78.
3. Maeshima K, Yamaoka K, Kubo S, et al. The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon-gamma and interleukin-17 production by human CD4+ T cells. Arthritis Rheum 2012;64:1790-98.
4. Kubo S, Yamaoka K, Kondo M, et al. The JAK inhibitor, tofacitinib, reduces the T cell stimulatory capacity of human monocyte-derived dendritic cells. Ann Rheum Dis Published Online First: 6 Sep 2013. doi:10.1136/annrheumdis-2013-203756
5. Muto A, Tashiro S, Nakajima O, et al. The transcriptional programme of antibody class switching involves the repressor Bach2. Nature 2004;429:566-71.
6. Kometani K, Nakagawa R, Shinnakasu R, et al. Repression of the transcription factor Bach2 contributes to predisposition of IgG1 memory B cells toward plasma cell differentiation. Immunity 2013;39:136-47.
7. Roychoudhuri R, Hirahara K, Mousavi K, et al. BACH2 represses effector programs to stabilize T(reg)-mediated immune homeostasis. Nature 2013;498:506-10.
8. Fillatreau S, Sweenie CH, McGeachy MJ, et al. B cells regulate autoimmunity by provision of IL-10. B cells regulate autoimmunity by provision of IL-10. Nat Immunol 2002;3:944-50.